Monografie
Assessing novel modalities for the therapy of inflammatory bowel disease
- Language
-
Englisch
- Identifier
-
1262238706
Subject
Therapeutics; Inflammatory bowel diseases
Contributor
Unterweger, Anna-Lena
Aszódi, Attila
Aszódi, Attila
- DOI
-
10.5282/edoc.30119
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
05.08.2022, 9:31 AM CEST
Object type
- Monografie
Associated
- Unterweger, Anna-Lena
- Aszódi, Attila
Other Objects (12)
Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel disease : a case-control study
Short- and long-term complications in pediatric inflammatory bowel disease patients, especially Crohn’s disease
Nanotools for cancer research and therapy
Augmenting bispecific T-cell engager (BiTE) therapy for the treatment of Acute Myeloid Leukemia
Hypoplastic left heart syndrome: surgical therapy
Development of gene correction and supplementation therapy based on chemical modification and sequence optimized mRNA for monogenetic diseases
Synthesis of modified oligonucleotides for prebiotic studies and as novel CoV-2 therapeutics
Pathophysiology of Niemann-Pick Type C and Fabry diseases with Emphasis on Membrane Composition and Protein Trafficking
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
The role of the TGFβ signaling pathway in clinically non-functioning pituitary adenoma and the potential role of inhibitors of this pathway as a new target in pituitary tumor therapy
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel disease : a case-control study
Short- and long-term complications in pediatric inflammatory bowel disease patients, especially Crohn’s disease
Nanotools for cancer research and therapy
Augmenting bispecific T-cell engager (BiTE) therapy for the treatment of Acute Myeloid Leukemia
Hypoplastic left heart syndrome: surgical therapy
Development of gene correction and supplementation therapy based on chemical modification and sequence optimized mRNA for monogenetic diseases
Synthesis of modified oligonucleotides for prebiotic studies and as novel CoV-2 therapeutics
Pathophysiology of Niemann-Pick Type C and Fabry diseases with Emphasis on Membrane Composition and Protein Trafficking
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
The role of the TGFβ signaling pathway in clinically non-functioning pituitary adenoma and the potential role of inhibitors of this pathway as a new target in pituitary tumor therapy
Characterization of bispecific antibodies that drive synthetic agonistic receptor-transduced T cells to mediate specific and conditional therapy in human pancreatic cancer models
Helicobacter pylori eradication therapy is not associated with the onset of inflammatory bowel disease : a case-control study
Short- and long-term complications in pediatric inflammatory bowel disease patients, especially Crohn’s disease
Nanotools for cancer research and therapy
Augmenting bispecific T-cell engager (BiTE) therapy for the treatment of Acute Myeloid Leukemia
Hypoplastic left heart syndrome: surgical therapy
Development of gene correction and supplementation therapy based on chemical modification and sequence optimized mRNA for monogenetic diseases
Synthesis of modified oligonucleotides for prebiotic studies and as novel CoV-2 therapeutics
Pathophysiology of Niemann-Pick Type C and Fabry diseases with Emphasis on Membrane Composition and Protein Trafficking
Low-dose imaging for particle therapy with fluence-modulated proton computed tomography
A patient-specific CT-Mesh hybrid computational phantom and its applications in out-of-field dose, equivalent dose, and secondary cancer risk estimation in proton therapy
The role of the TGFβ signaling pathway in clinically non-functioning pituitary adenoma and the potential role of inhibitors of this pathway as a new target in pituitary tumor therapy